FF News Logo
Wednesday, February 12, 2025
FKV2483 - FinovateEurope - FFNews banner - 728x90
Mark Yung | Pacific Western Bank | Fintech Finance

About Mark Yung

http://www.pacwest.com/
Mr. Mark Yung has served as a director of the PacWest Bancorp since 2017 and he is currently a member of the Risk Committee. He is also EVP, Chief Operating Officer of PacWest Bancorp and Pacific Western Bank. Prior to joining the Company, Mr. Yung was co-founder and managing principal of OCV Management, LLC, an investor, owner and operator of technology and life science companies based in Los Angeles. He served as managing director of Orchard Capital Corp. (“Orchard Capital”), a firm he joined in 2006. He served in various senior capacities including, among others, as chairman and chief executive officer of Presbia PLC, an ophthalmic device company, executive chairman of the board of directors of Environmental Solutions Worldwide, Inc., a clean technology company focused on the reduction of diesel emissions, chief financial officer and director of Polymer Plainfield Holdings, Inc., an OEM automotive supplier with operations in the United States, Canada, Mexico and the Caribbean, chairman of the board of Vantage Surgical Systems, Inc., director of Red Carpet Cinema Corporation and as a director and/or officer of Coreolis Holdings and Tradewinds Holdings. Prior to joining Orchard Capital, Mark Yung served as a senior vice president in the Corporate Strategy and Merger and Acquisitions groups of Citigroup in New York and ABN AMRO in Amsterdam, Netherlands. Prior to his corporate strategy roles, He served as an investment professional at JPMorgan Partners (“JPMP”). At JPMP, He focused on venture capital, growth equity and buyout transactions in Latin America and served as a board member for various emerging companies in the region. Mark Yung began his career in 1996 at Chase Securities, Inc., focusing on leveraged finance for cross border buyouts and privatizations. Mark Yung, - Entrepreneurial operator of innovation focused companies ranging from medical device, clean technology to telecommunications - Seasoned investor who co-founded and co-managed a $260 million technology and biotech focused venture fund

News